{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lombardi Z"],"funding":["Associazione Italiana per la Ricerca sul Cancro","Ministero dell'Istruzione, dell'Università e della Ricerca","European Union","Fondazione AIRC per la ricerca sul cancro ETS","European Union Horizon 2020 Research and Innovation Program","Fondazione Cassa di Risparmio di Firenze","European Commission"],"pagination":["99-113"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11705758"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["19(1)"],"pubmed_abstract":["The mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase 5 (ERK5) is emerging as a promising target in cancer. Indeed, alterations of the MEK5/ERK5 pathway are present in many types of cancer, including melanoma. One of the key events in MAPK signalling is MAPK nuclear translocation and its subsequent regulation of gene expression. Likewise, the effects of ERK5 in supporting cancer cell proliferation have been linked to its nuclear localization. Despite many processes regulating ERK5 nuclear translocation having been determined, the nuclear transporters involved have not yet been identified. Here, we investigated the role of importin subunit alpha (α importin) and importin subunit beta-1 (importin β1) in ERK5 nuclear shuttling to identify additional targets for can"],"journal":["Molecular oncology"],"pubmed_title":["Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation."],"pmcid":["PMC11705758"],"funding_grant_id":["ID‐23847","ID-23847","IG-21349","871124","IG‐21349"],"pubmed_authors":["Lombardi Z","Kashchuk AV","Stecca B","Tubita A","Rovida E","Tusa I","Gardini L","Menconi A","Lulli M","Maresca L","Capitanio M"],"additional_accession":[]},"is_claimable":false,"name":"Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation.","description":"The mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase 5 (ERK5) is emerging as a promising target in cancer. Indeed, alterations of the MEK5/ERK5 pathway are present in many types of cancer, including melanoma. One of the key events in MAPK signalling is MAPK nuclear translocation and its subsequent regulation of gene expression. Likewise, the effects of ERK5 in supporting cancer cell proliferation have been linked to its nuclear localization. Despite many processes regulating ERK5 nuclear translocation having been determined, the nuclear transporters involved have not yet been identified. Here, we investigated the role of importin subunit alpha (α importin) and importin subunit beta-1 (importin β1) in ERK5 nuclear shuttling to identify additional targets for can","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2026-06-02T07:09:16.385Z","creation":"2025-04-04T21:49:54.769Z"},"accession":"S-EPMC11705758","cross_references":{"pubmed":["38965815"],"doi":["10.1002/1878-0261.13674"]}}